Suvorexant

Suvorexant, sold under the trade name Belsomra, is a medication for the treatment of insomnia.It is effective for insomnia, at least for four weeks and as compared to a placebo. The drug was initially released November 2014 in Japan, then later reached the United States in February 2015, Australia in November 2016, and Canada in November 2018.